Article
Teva CEO says not too late to launch Humira biosimilar in 2024
Rating:
0.0
Views:
97
Likes:
1
Library:
1
Teva Pharmaceutical Industries will still pursue launching a biosimilar of AbbVie's blockbuster arthritis drug Humira next year despite a crowded marketplace, Chief Executive Richard Francis said on Wednesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value